Teva Pharma Industries Stock Today
| TEVA Stock | USD 12.78 0.40 3.03% |
Performance8 of 100
| Odds Of DistressLess than 39
|
Teva Pharma is trading at 12.78 as of the 19th of April 2024, a -3.03% down since the beginning of the trading day. The stock's open price was 13.18. Teva Pharma has about a 39 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Teva Pharma Industries are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 26th of March 1990 | Category Healthcare | Classification Health Care |
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. The company has 1.13 B outstanding shares of which 11.56 M shares are at this time shorted by private and institutional investors with about 1.34 trading days to cover. More on Teva Pharma Industries
Moving together with Teva Stock
| 0.8 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.79 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
Moving against Teva Stock
| 0.8 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.79 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.76 | VCYT | Veracyte Financial Report 2nd of May 2024 | PairCorr |
| 0.73 | DMTK | DermTech Financial Report 2nd of May 2024 | PairCorr |
| 0.73 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.69 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.67 | ME | 23Andme Holding | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 8th of May 2024
Teva Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Teva Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Teva Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Teva Pharma's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Teva Pharma's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| CEO | Carlo Notaristefani | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, Tel Aviv 35, ARCA Pharmaceutical, BETTERINVESTING 100 INDEX, BTRINVSTNG 100 INDEX, Tel Aviv 125, Adviser Favorites, Israel Wall Street, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal TestingCatholic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Teva Pharma report their recommendations after researching Teva Pharma's financial statements, talking to executives and customers, or listening in on Teva Pharma's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Teva Pharma Industries. The Teva consensus assessment is calculated by taking the average forecast from all of the analysts covering Teva Pharma. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Teva Pharma's financial statements, Teva Pharma Industries may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Teva Pharma Industries is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Teva Pharma's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Teva Pharma's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Teva Pharma's financial leverage. It provides some insight into what part of Teva Pharma's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Teva Pharma Industries (TEVA) is traded on New York Stock Exchange in USA. It is located in 124 Dvora HaNevi?a Street, Tel Aviv, Israel, 6944020 and employs 35,001 people. Teva Pharma is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 14.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Teva Pharma's market, we take the total number of its shares issued and multiply it by Teva Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Teva Pharma Industries conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 1.13 B outstanding shares of which 11.56 M shares are at this time shorted by private and institutional investors with about 1.34 trading days to cover.
Teva Pharma Industries currently holds about 2.22 B in cash with 1.37 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.0.
Check Teva Pharma Probability Of Bankruptcy
Ownership AllocationTeva Pharma Industries shows a total of 1.13 Billion outstanding shares. Over half of Teva Pharma's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Teva Pharma Industries. Please watch out for any change in the institutional holdings of Teva Pharma as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Teva Ownership Details
Teva Stock Price Odds Analysis
What are Teva Pharma's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Teva Pharma jumping above the current price in 90 days from now is about 60.75%. The Teva Pharma Industries probability density function shows the probability of Teva Pharma stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Teva Pharma has a beta of 0.8912. This usually implies Teva Pharma Industries market returns are sensitive to returns on the market. As the market goes up or down, Teva Pharma is expected to follow. Additionally, teva Pharma Industries has an alpha of 0.1809, implying that it can generate a 0.18 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Teva Pharma to move above the current price in 90 days from now is about 60.75 (This Teva Pharma Industries probability density function shows the probability of Teva Stock to fall within a particular range of prices over 90 days) .
Teva Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Teva Pharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Teva Pharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Teva Pharma's value.| Instituion | Recorded On | Shares | |
| Millennium Management Llc | 2023-12-31 | 15.1 M | |
| Capital Research & Mgmt Co - Division 3 | 2023-12-31 | 10 M | |
| Australiansuper Pty Ltd | 2023-12-31 | 9 M | |
| Sound Shore Management Inc | 2023-12-31 | 8.9 M | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 8.2 M | |
| Geode Capital Management, Llc | 2023-12-31 | 7.8 M | |
| Goldman Sachs Group Inc | 2023-12-31 | 7.6 M | |
| Alyeska Investment Group, L.p. | 2023-09-30 | 6.5 M | |
| Eversept Partners, Llc | 2023-12-31 | 6.2 M | |
| Blackrock Inc | 2023-12-31 | 41.7 M | |
| Ion Asset Management Ltd. | 2023-12-31 | 40.3 M |
Teva Pharma Historical Income Statement
Teva Pharma Industries Income Statement is one of the three primary financial statements used for reporting Teva's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Teva Pharma Industries revenue and expense. Teva Pharma Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Teva Pharma's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Operating Income is expected to grow to about 732.2 M, whereas Depreciation And Amortization is forecasted to decline to about 667.3 M. View More FundamentalsTeva Stock Against Markets
Picking the right benchmark for Teva Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Teva Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Teva Pharma is critical whether you are bullish or bearish towards Teva Pharma Industries at a given time. Please also check how Teva Pharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Teva Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Teva Pharma Corporate Directors
Teva Pharma corporate directors refer to members of a Teva Pharma board of directors. The board of directors generally takes responsibility for the Teva Pharma's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Teva Pharma's board members must vote for the resolution. The Teva Pharma board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Moshe Many | Independent Director | Profile | |
| Richard Lerner | Independent Director | Profile | |
| Galia Maor | Independent Director | Profile | |
| JeanMichel Halfon | Statutory - independent director | Profile |
How to buy Teva Stock?
Before investing in Teva Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Teva Pharma. To buy Teva Pharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Teva Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Teva Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Teva Pharma Industries stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Teva Pharma Industries stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Teva Pharma Industries, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Teva Stock please use our How to Invest in Teva Pharma guide.
Already Invested in Teva Pharma Industries?
The danger of trading Teva Pharma Industries is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Teva Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Teva Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Teva Pharma Industries is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Teva Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.4 | Earnings Share (0.50) | Revenue Per Share 14.161 | Quarterly Revenue Growth 0.148 | Return On Assets 0.0454 |
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.